Meet the Expert

CAREER

​

Dr. Sipple began his career as a physician on faculty at the Shirley Ryan Ability, the leading Rehabilitation Hospital in the United States in U.S. News and World Report for over 30 years running. He staffed the Shirley Ryan Ability Lab Pain Center and the American Academy of Pain Medicine Center of Excellence before working alongside former Denver Broncos and Colorado Rockies team physicians at Advanced Orthopedics and Sports Medicine Specialists, P.C. Dr. Sipple took full Orthopedic Surgery Call. Subsequently, Dr. Sipple was on staff at the Mayo Clinic in Eau Claire, Wisconsin, via the Pain Clinic of Northwestern Wisconsin in a high-volume, Anesthesia-based interventional pain practice. Thereafter, Dr. Sipple led the turnaround of the HealthEast Spine Center as Medical Director and Service line Medical Director, growing volume over an order of magnitude over two years.  He subsequently served as an interventional physiatrist at Midwest Spine and Brain Institute for 7 years, caring for complex spine and pain patients. He is double-board certified. This background provides clinical expertise for the medical-legal community.

 

POLICY

​

​On the policy side, Dr. Sipple is a Society for Brain Mapping and Therapeutics (SBMT) member, previously serving on the board of directors. As a NASA spinout thinktank and a legacy of President Obama’s Brain Initiative, SBMT has successfully lobbied the U.S. Department of Commerce for $500 Million Tech Park Initiative to fast-track therapeutics. In addition to supporting national policy, Dr. Sipple has represented the U.S. Delegation to the Neuroscience 20 in Buenos Aires, Argentina, Osaka, Japan, and New Delhi, India, to lobby the G20 to include Neuroscience fully. Thinktank papers on the burden of Neurological disease, co-authored by Dr. Sipple, have been internationally recognized. This background provides clinical expertise for the medical-legal community.

 

COMPANY CO-FOUNDER AND FOUNDER

​

Dr. Sipple is a Commonwealth Entrepreneur’s Club member and co-founded InSitu Biologics. He also co-patented the hyaluronic-based drug delivery platform to reduce opioid consumption. The predicate company in the space, Pacira, is a unicorn, driving surgeries from the hospital to lower the cost of care in ASC and simultaneously reducing opioid exposure. It is estimated that sustained release anesthetics saved Medicare, not counting commercial insurance or Medicaid, $34 Billion in 2019. InSitu Biologics has partnered with the Mayo Clinic and invested in developing Dr. Sipple’s co-patented drug delivery platform for cancer therapeutic delivery. As an interventional pain physician, Dr. Sipple recognized the limitations of needles and the Medicare Never Event of inadvertent embolism, which has catastrophic complications. To address this, he founded Acies Medical and currently leads a team of experts improving tech and care in this arena. From Botox to Brazilian Butt lifts, deep brain stimulator implantation to vaccine emboli-induced myocarditis that drives vaccine hesitancy, the team at Acies is moving the needle. 

 

________________________________________

More recently, Dr. Sipple was solicited to join the team at Hypercharge. Hypercharge is moving to quantify the effects of FDA-approved wellness devices such as Exercise with Oxygen Therapy, Class IV Laser, NanoVi Structured Water Therapy, Photobiomodulation, NuCalm, and more. Such promising tech has substantial utility and impact yet has underpenetrated the healthcare market and the benefits accrued by an entrepreneurial escort.
_________________________________________

 

TECH INNOVATIONS

​

Dr. Sipple’s interests focus social impact tech that has under-penetrated the marketplace. He serves on the board of directors of Kinuu, gamified Occupational Therapy for Autism, Asperger, ADHD, and Dyslexia. The average wait for an Autism Clinic is one year. Hedge funds are active acquirers of such clinics, which profit an annual average of $10 Million USD. Lowering cost and caregiver burden with a home-based therapy such as Brainyact by Kinuu, should outcomes and data continue to bear out, has a substantial social impact and will be a welcome addition to the marketplace.

​

NuCalm is a neuroacoustic form of neurofeedback that regulates the autonomic nervous system to assist those with trauma to self soothe and regulate, drug free. Backed by the U.S. Department of Defense for PTSD, and by over 50 professional sports teams for performance enhancement, Dr. Sipple collaborates with NuCalm to expand it’s market presence and social impact.                                                            

​

Dr. Sipple has recently joined the Board of Directors at Thera Clean. Oxygen Microbubbles, first pioneered in the cardiac space for use in echocardiography, have been repurposed for cleaning in pets. Billions of small oxygen microbubbles, smaller than a red blood cell, perfuse tissue and penetrate and lift out toxins from the skin. The high oxygen content has been observed to not only clean but heal wounds and infections. In case studies from the Department of Dermatology at Northwestern University, TheraClean has radically improved previously untreatable condition known as ichthyosis, a rare scaling skin disorder. Given this response, applications for broader use, such as skin aesthetics, acne, wounds, diabetic feet, autoimmune rash manifestations, and challenging polymicrobial infections, are on the horizon, and Thera Clean is in process with the FDA use in humans.  

​

Dr. Sipple supports the research of Dr. Jeffrey Leighton, Ph. D., at the Prayer Collective in Excelsior, MN. Dr. Leighton is experienced in the application of Neurofeedback and photobiomodulation. Dr. Leighton's research was used extensively in conjunction with the Government of the State of Michigan to scale non-drug research and treatment of neurofeedback to those with substance use disorders.